nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifampicin—UGT1A1—Mycophenolic acid—psoriasis	0.0535	0.0581	CbGbCtD
Rifampicin—CYP4A11—Dexamethasone—psoriasis	0.0416	0.0451	CbGbCtD
Rifampicin—CYP3A43—Dexamethasone—psoriasis	0.0416	0.0451	CbGbCtD
Rifampicin—SLCO1B3—Mycophenolate mofetil—psoriasis	0.0355	0.0386	CbGbCtD
Rifampicin—CYP2A6—Methoxsalen—psoriasis	0.0309	0.0336	CbGbCtD
Rifampicin—ABCC3—Cyclosporine—psoriasis	0.0303	0.0329	CbGbCtD
Rifampicin—UGT1A1—Mycophenolate mofetil—psoriasis	0.0299	0.0325	CbGbCtD
Rifampicin—ABCB11—Cyclosporine—psoriasis	0.0262	0.0285	CbGbCtD
Rifampicin—CYP2C8—Tazarotene—psoriasis	0.0237	0.0257	CbGbCtD
Rifampicin—CYP3A5—Beclomethasone—psoriasis	0.0229	0.0248	CbGbCtD
Rifampicin—CYP1A2—Clobetasol propionate—psoriasis	0.0225	0.0244	CbGbCtD
Rifampicin—SLCO1B1—Mycophenolate mofetil—psoriasis	0.0207	0.0225	CbGbCtD
Rifampicin—ABCC1—Cyclosporine—psoriasis	0.0186	0.0202	CbGbCtD
Rifampicin—SLCO1A2—Prednisolone—psoriasis	0.0186	0.0202	CbGbCtD
Rifampicin—ABCC2—Mycophenolate mofetil—psoriasis	0.0182	0.0198	CbGbCtD
Rifampicin—SLCO1A2—Hydrocortisone—psoriasis	0.0176	0.0191	CbGbCtD
Rifampicin—SLCO1A2—Prednisone—psoriasis	0.0175	0.019	CbGbCtD
Rifampicin—ABCB11—Dexamethasone—psoriasis	0.0173	0.0187	CbGbCtD
Rifampicin—SLCO1A2—Cyclosporine—psoriasis	0.0166	0.0181	CbGbCtD
Rifampicin—ABCC3—Methotrexate—psoriasis	0.016	0.0174	CbGbCtD
Rifampicin—SLCO1B1—Cyclosporine—psoriasis	0.0157	0.017	CbGbCtD
Rifampicin—CYP2A6—Prednisolone—psoriasis	0.015	0.0163	CbGbCtD
Rifampicin—SLCO1B3—Methotrexate—psoriasis	0.0142	0.0155	CbGbCtD
Rifampicin—ABCC2—Cyclosporine—psoriasis	0.0138	0.015	CbGbCtD
Rifampicin—CYP2B6—Cholecalciferol—psoriasis	0.0133	0.0145	CbGbCtD
Rifampicin—SLC22A7—Methotrexate—psoriasis	0.0125	0.0136	CbGbCtD
Rifampicin—CYP1A2—Methoxsalen—psoriasis	0.0118	0.0128	CbGbCtD
Rifampicin—SLCO1A2—Dexamethasone—psoriasis	0.0109	0.0119	CbGbCtD
Rifampicin—CYP2C8—Cholecalciferol—psoriasis	0.0101	0.011	CbGbCtD
Rifampicin—ABCC1—Methotrexate—psoriasis	0.00985	0.0107	CbGbCtD
Rifampicin—CYP3A7—Hydrocortisone—psoriasis	0.00974	0.0106	CbGbCtD
Rifampicin—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.00974	0.0106	CbGbCtD
Rifampicin—CYP3A7—Cyclosporine—psoriasis	0.0092	0.00999	CbGbCtD
Rifampicin—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.0092	0.00999	CbGbCtD
Rifampicin—CYP3A5—Mycophenolate mofetil—psoriasis	0.00911	0.00989	CbGbCtD
Rifampicin—ABCC2—Dexamethasone—psoriasis	0.00907	0.00986	CbGbCtD
Rifampicin—CYP2A6—Dexamethasone—psoriasis	0.00886	0.00963	CbGbCtD
Rifampicin—SLCO1A2—Methotrexate—psoriasis	0.0088	0.00955	CbGbCtD
Rifampicin—CYP2C8—Mycophenolate mofetil—psoriasis	0.00876	0.00951	CbGbCtD
Rifampicin—CYP2C19—Cholecalciferol—psoriasis	0.00847	0.0092	CbGbCtD
Rifampicin—SLCO1B1—Methotrexate—psoriasis	0.0083	0.00901	CbGbCtD
Rifampicin—CYP3A4—Calcitriol—psoriasis	0.00795	0.00864	CbGbCtD
Rifampicin—CYP3A5—Hydrocortisone—psoriasis	0.00731	0.00794	CbGbCtD
Rifampicin—ABCC2—Methotrexate—psoriasis	0.00729	0.00792	CbGbCtD
Rifampicin—CYP2C9—Cholecalciferol—psoriasis	0.00704	0.00765	CbGbCtD
Rifampicin—CYP2C8—Hydrocortisone—psoriasis	0.00703	0.00763	CbGbCtD
Rifampicin—CYP3A5—Cyclosporine—psoriasis	0.0069	0.0075	CbGbCtD
Rifampicin—CYP2C8—Cyclosporine—psoriasis	0.00664	0.00721	CbGbCtD
Rifampicin—CYP3A4—Methoxsalen—psoriasis	0.00618	0.00672	CbGbCtD
Rifampicin—CYP3A7—Dexamethasone—psoriasis	0.00606	0.00658	CbGbCtD
Rifampicin—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.00606	0.00658	CbGbCtD
Rifampicin—ABCB1—Mycophenolate mofetil—psoriasis	0.00593	0.00644	CbGbCtD
Rifampicin—CYP2C19—Prednisone—psoriasis	0.00587	0.00638	CbGbCtD
Rifampicin—CYP2E1—Dexamethasone—psoriasis	0.00585	0.00635	CbGbCtD
Rifampicin—CYP2B6—Dexamethasone—psoriasis	0.00577	0.00627	CbGbCtD
Rifampicin—CYP2C19—Cyclosporine—psoriasis	0.00557	0.00605	CbGbCtD
Rifampicin—ABCB1—Betamethasone—psoriasis	0.00508	0.00552	CbGbCtD
Rifampicin—ABCB1—Prednisolone—psoriasis	0.00502	0.00545	CbGbCtD
Rifampicin—ABCB1—Hydrocortisone—psoriasis	0.00476	0.00517	CbGbCtD
Rifampicin—ABCB1—Prednisone—psoriasis	0.00474	0.00515	CbGbCtD
Rifampicin—CYP2C9—Cyclosporine—psoriasis	0.00463	0.00503	CbGbCtD
Rifampicin—CYP3A5—Dexamethasone—psoriasis	0.00454	0.00494	CbGbCtD
Rifampicin—ABCB1—Cyclosporine—psoriasis	0.00449	0.00488	CbGbCtD
Rifampicin—CYP2C8—Dexamethasone—psoriasis	0.00437	0.00475	CbGbCtD
Rifampicin—CYP3A4—Cholecalciferol—psoriasis	0.0041	0.00445	CbGbCtD
Rifampicin—CYP2C19—Dexamethasone—psoriasis	0.00367	0.00398	CbGbCtD
Rifampicin—CYP3A4—Mycophenolate mofetil—psoriasis	0.00355	0.00386	CbGbCtD
Rifampicin—CYP3A4—Triamcinolone—psoriasis	0.00355	0.00386	CbGbCtD
Rifampicin—CYP2C9—Dexamethasone—psoriasis	0.00305	0.00331	CbGbCtD
Rifampicin—CYP3A4—Betamethasone—psoriasis	0.00305	0.00331	CbGbCtD
Rifampicin—CYP3A4—Prednisolone—psoriasis	0.00301	0.00327	CbGbCtD
Rifampicin—ABCB1—Dexamethasone—psoriasis	0.00296	0.00321	CbGbCtD
Rifampicin—CYP3A4—Hydrocortisone—psoriasis	0.00285	0.0031	CbGbCtD
Rifampicin—CYP3A4—Prednisone—psoriasis	0.00284	0.00308	CbGbCtD
Rifampicin—CYP3A4—Cyclosporine—psoriasis	0.00269	0.00292	CbGbCtD
Rifampicin—ABCB1—Methotrexate—psoriasis	0.00238	0.00258	CbGbCtD
Rifampicin—CYP3A4—Dexamethasone—psoriasis	0.00177	0.00193	CbGbCtD
Rifampicin—SLCO1A2—SLC-mediated transmembrane transport—CP—psoriasis	0.000115	0.00144	CbGpPWpGaD
Rifampicin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000114	0.00143	CbGpPWpGaD
Rifampicin—ABCB1—Allograft Rejection—HLA-C—psoriasis	0.000114	0.00143	CbGpPWpGaD
Rifampicin—ABCB1—Allograft Rejection—IL13—psoriasis	0.000113	0.00142	CbGpPWpGaD
Rifampicin—CYP1A2—Biological oxidations—CYP2S1—psoriasis	0.000107	0.00134	CbGpPWpGaD
Rifampicin—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	0.000105	0.00132	CbGpPWpGaD
Rifampicin—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	0.000105	0.00132	CbGpPWpGaD
Rifampicin—CYP3A43—Metabolism—CYP2S1—psoriasis	0.000104	0.00131	CbGpPWpGaD
Rifampicin—ABCB1—Allograft Rejection—IL17A—psoriasis	0.000104	0.00131	CbGpPWpGaD
Rifampicin—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	0.000103	0.0013	CbGpPWpGaD
Rifampicin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	9.94e-05	0.00125	CbGpPWpGaD
Rifampicin—SLCO1B1—SLC-mediated transmembrane transport—CP—psoriasis	9.82e-05	0.00124	CbGpPWpGaD
Rifampicin—ABCC5—Metabolism—NDUFA5—psoriasis	9.78e-05	0.00123	CbGpPWpGaD
Rifampicin—ABCB1—Allograft Rejection—IL12B—psoriasis	9.66e-05	0.00122	CbGpPWpGaD
Rifampicin—SLCO2B1—Transmembrane transport of small molecules—CP—psoriasis	9.51e-05	0.0012	CbGpPWpGaD
Rifampicin—NR1I2—Generic Transcription Pathway—VDR—psoriasis	9.48e-05	0.00119	CbGpPWpGaD
Rifampicin—ABCB1—Allograft Rejection—HLA-E—psoriasis	9.43e-05	0.00119	CbGpPWpGaD
Rifampicin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	9.28e-05	0.00117	CbGpPWpGaD
Rifampicin—CYP1A2—Tryptophan metabolism—CAT—psoriasis	9.21e-05	0.00116	CbGpPWpGaD
Rifampicin—ABCC5—Transmembrane transport of small molecules—CP—psoriasis	9.09e-05	0.00114	CbGpPWpGaD
Rifampicin—SLCO2B1—Transmembrane transport of small molecules—CARM1—psoriasis	9.07e-05	0.00114	CbGpPWpGaD
Rifampicin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	9.03e-05	0.00114	CbGpPWpGaD
Rifampicin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	8.78e-05	0.0011	CbGpPWpGaD
Rifampicin—ABCC5—Transmembrane transport of small molecules—CARM1—psoriasis	8.67e-05	0.00109	CbGpPWpGaD
Rifampicin—CYP4A11—Metabolism—NDUFA5—psoriasis	8.48e-05	0.00107	CbGpPWpGaD
Rifampicin—ABCC5—Metabolism—CYP2S1—psoriasis	8.32e-05	0.00105	CbGpPWpGaD
Rifampicin—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	8.27e-05	0.00104	CbGpPWpGaD
Rifampicin—CYP3A4—Biological oxidations—CYP2S1—psoriasis	8.23e-05	0.00104	CbGpPWpGaD
Rifampicin—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	8.12e-05	0.00102	CbGpPWpGaD
Rifampicin—CYP2A6—Fluoropyrimidine Activity—TP53—psoriasis	8.01e-05	0.00101	CbGpPWpGaD
Rifampicin—SLCO1B3—Metabolism—NDUFA5—psoriasis	7.99e-05	0.00101	CbGpPWpGaD
Rifampicin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	7.93e-05	0.000998	CbGpPWpGaD
Rifampicin—CYP4A11—Metabolism of lipids and lipoproteins—CARM1—psoriasis	7.91e-05	0.000995	CbGpPWpGaD
Rifampicin—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	7.9e-05	0.000993	CbGpPWpGaD
Rifampicin—SLC22A7—Transmembrane transport of small molecules—CP—psoriasis	7.82e-05	0.000983	CbGpPWpGaD
Rifampicin—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	7.81e-05	0.000982	CbGpPWpGaD
Rifampicin—NR1I2—Gene Expression—CARM1—psoriasis	7.65e-05	0.000962	CbGpPWpGaD
Rifampicin—ABCB11—Metabolism—NDUFA5—psoriasis	7.52e-05	0.000946	CbGpPWpGaD
Rifampicin—SLC22A7—Transmembrane transport of small molecules—CARM1—psoriasis	7.46e-05	0.000938	CbGpPWpGaD
Rifampicin—SLCO1B3—Metabolism of lipids and lipoproteins—CARM1—psoriasis	7.45e-05	0.000937	CbGpPWpGaD
Rifampicin—SLCO1B3—Transmembrane transport of small molecules—CP—psoriasis	7.43e-05	0.000934	CbGpPWpGaD
Rifampicin—ABCC3—Metabolism—NDUFA5—psoriasis	7.21e-05	0.000907	CbGpPWpGaD
Rifampicin—CYP4A11—Metabolism—CYP2S1—psoriasis	7.21e-05	0.000907	CbGpPWpGaD
Rifampicin—CYP3A4—Tryptophan metabolism—CAT—psoriasis	7.1e-05	0.000894	CbGpPWpGaD
Rifampicin—SLCO1B3—Transmembrane transport of small molecules—CARM1—psoriasis	7.09e-05	0.000891	CbGpPWpGaD
Rifampicin—ABCB1—Allograft Rejection—IL10—psoriasis	7.06e-05	0.000889	CbGpPWpGaD
Rifampicin—ABCB11—Metabolism of lipids and lipoproteins—CARM1—psoriasis	7.01e-05	0.000882	CbGpPWpGaD
Rifampicin—ABCB1—Allograft Rejection—IL4—psoriasis	6.87e-05	0.000864	CbGpPWpGaD
Rifampicin—SLCO1B3—Metabolism—CYP2S1—psoriasis	6.8e-05	0.000855	CbGpPWpGaD
Rifampicin—ABCC3—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.72e-05	0.000846	CbGpPWpGaD
Rifampicin—ABCB1—Allograft Rejection—HLA-B—psoriasis	6.72e-05	0.000845	CbGpPWpGaD
Rifampicin—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	6.71e-05	0.000844	CbGpPWpGaD
Rifampicin—ABCC3—Transmembrane transport of small molecules—CP—psoriasis	6.7e-05	0.000843	CbGpPWpGaD
Rifampicin—NR1I2—Generic Transcription Pathway—PPARG—psoriasis	6.61e-05	0.000832	CbGpPWpGaD
Rifampicin—ABCB11—Metabolism—CYP2S1—psoriasis	6.4e-05	0.000804	CbGpPWpGaD
Rifampicin—ABCC3—Transmembrane transport of small molecules—CARM1—psoriasis	6.39e-05	0.000804	CbGpPWpGaD
Rifampicin—SLCO1A2—Metabolism—NDUFA5—psoriasis	6.28e-05	0.00079	CbGpPWpGaD
Rifampicin—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	6.25e-05	0.000787	CbGpPWpGaD
Rifampicin—ABCB1—Allograft Rejection—HLA-A—psoriasis	6.23e-05	0.000783	CbGpPWpGaD
Rifampicin—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	6.15e-05	0.000774	CbGpPWpGaD
Rifampicin—ABCC3—Metabolism—CYP2S1—psoriasis	6.13e-05	0.000771	CbGpPWpGaD
Rifampicin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	6.12e-05	0.00077	CbGpPWpGaD
Rifampicin—UGT1A1—Metabolism—NDUFA5—psoriasis	5.86e-05	0.000737	CbGpPWpGaD
Rifampicin—SLCO1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	5.85e-05	0.000736	CbGpPWpGaD
Rifampicin—SLCO1A2—Transmembrane transport of small molecules—CP—psoriasis	5.84e-05	0.000734	CbGpPWpGaD
Rifampicin—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	5.69e-05	0.000715	CbGpPWpGaD
Rifampicin—ABCC1—Metabolism—NDUFA5—psoriasis	5.65e-05	0.000711	CbGpPWpGaD
Rifampicin—SLCO1A2—Transmembrane transport of small molecules—CARM1—psoriasis	5.57e-05	0.0007	CbGpPWpGaD
Rifampicin—SLCO1B1—Metabolism—NDUFA5—psoriasis	5.37e-05	0.000675	CbGpPWpGaD
Rifampicin—SLCO1A2—Metabolism—CYP2S1—psoriasis	5.34e-05	0.000672	CbGpPWpGaD
Rifampicin—ABCC2—Transmembrane transport of small molecules—CP—psoriasis	5.31e-05	0.000668	CbGpPWpGaD
Rifampicin—ABCC1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	5.27e-05	0.000663	CbGpPWpGaD
Rifampicin—ABCC1—Transmembrane transport of small molecules—CP—psoriasis	5.25e-05	0.00066	CbGpPWpGaD
Rifampicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	5.11e-05	0.000643	CbGpPWpGaD
Rifampicin—CYP3A43—Metabolism—CARM1—psoriasis	5.08e-05	0.000639	CbGpPWpGaD
Rifampicin—ABCC2—Transmembrane transport of small molecules—CARM1—psoriasis	5.07e-05	0.000638	CbGpPWpGaD
Rifampicin—ABCC1—Transmembrane transport of small molecules—CARM1—psoriasis	5.01e-05	0.00063	CbGpPWpGaD
Rifampicin—SLCO1B1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	5.01e-05	0.00063	CbGpPWpGaD
Rifampicin—SLCO1B1—Transmembrane transport of small molecules—CP—psoriasis	4.99e-05	0.000628	CbGpPWpGaD
Rifampicin—UGT1A1—Metabolism—CYP2S1—psoriasis	4.98e-05	0.000627	CbGpPWpGaD
Rifampicin—CYP3A7—Metabolism—NDUFA5—psoriasis	4.93e-05	0.00062	CbGpPWpGaD
Rifampicin—ABCC1—Metabolism—CYP2S1—psoriasis	4.8e-05	0.000604	CbGpPWpGaD
Rifampicin—SLCO1B1—Transmembrane transport of small molecules—CARM1—psoriasis	4.76e-05	0.000599	CbGpPWpGaD
Rifampicin—NR1I2—Gene Expression—VDR—psoriasis	4.57e-05	0.000574	CbGpPWpGaD
Rifampicin—SLCO1B1—Metabolism—CYP2S1—psoriasis	4.57e-05	0.000574	CbGpPWpGaD
Rifampicin—CYP2A6—Metabolism—NDUFA5—psoriasis	4.52e-05	0.000568	CbGpPWpGaD
Rifampicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	4.42e-05	0.000556	CbGpPWpGaD
Rifampicin—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	4.25e-05	0.000535	CbGpPWpGaD
Rifampicin—CYP3A7—Metabolism—CYP2S1—psoriasis	4.19e-05	0.000527	CbGpPWpGaD
Rifampicin—ABCB1—Allograft Rejection—IFNG—psoriasis	4.15e-05	0.000523	CbGpPWpGaD
Rifampicin—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	4.15e-05	0.000522	CbGpPWpGaD
Rifampicin—ABCC5—Metabolism—CARM1—psoriasis	4.06e-05	0.000511	CbGpPWpGaD
Rifampicin—ABCB1—Allograft Rejection—CXCL8—psoriasis	3.86e-05	0.000486	CbGpPWpGaD
Rifampicin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	3.86e-05	0.000486	CbGpPWpGaD
Rifampicin—CYP2A6—Metabolism—CYP2S1—psoriasis	3.84e-05	0.000483	CbGpPWpGaD
Rifampicin—CYP4A11—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.78e-05	0.000475	CbGpPWpGaD
Rifampicin—CYP2B6—Metabolism—NDUFA5—psoriasis	3.64e-05	0.000458	CbGpPWpGaD
Rifampicin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	3.62e-05	0.000456	CbGpPWpGaD
Rifampicin—CYP2E1—Metabolism—NDUFA5—psoriasis	3.57e-05	0.000449	CbGpPWpGaD
Rifampicin—CYP3A5—Metabolism—NDUFA5—psoriasis	3.56e-05	0.000448	CbGpPWpGaD
Rifampicin—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.56e-05	0.000448	CbGpPWpGaD
Rifampicin—CYP4A11—Metabolism—CARM1—psoriasis	3.52e-05	0.000443	CbGpPWpGaD
Rifampicin—ABCB11—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.35e-05	0.000422	CbGpPWpGaD
Rifampicin—SLCO1B3—Metabolism—CARM1—psoriasis	3.32e-05	0.000417	CbGpPWpGaD
Rifampicin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	3.31e-05	0.000416	CbGpPWpGaD
Rifampicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	3.31e-05	0.000416	CbGpPWpGaD
Rifampicin—CYP4A11—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.29e-05	0.000414	CbGpPWpGaD
Rifampicin—ABCC3—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.21e-05	0.000404	CbGpPWpGaD
Rifampicin—NR1I2—Gene Expression—PPARG—psoriasis	3.18e-05	0.0004	CbGpPWpGaD
Rifampicin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	3.18e-05	0.0004	CbGpPWpGaD
Rifampicin—ABCB1—Allograft Rejection—VEGFA—psoriasis	3.14e-05	0.000395	CbGpPWpGaD
Rifampicin—CYP3A43—Metabolism—CAT—psoriasis	3.12e-05	0.000393	CbGpPWpGaD
Rifampicin—ABCB11—Metabolism—CARM1—psoriasis	3.12e-05	0.000393	CbGpPWpGaD
Rifampicin—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.1e-05	0.00039	CbGpPWpGaD
Rifampicin—CYP2B6—Metabolism—CYP2S1—psoriasis	3.1e-05	0.00039	CbGpPWpGaD
Rifampicin—CYP2C8—Metabolism—NDUFA5—psoriasis	3.09e-05	0.000388	CbGpPWpGaD
Rifampicin—CYP2E1—Metabolism—CYP2S1—psoriasis	3.04e-05	0.000382	CbGpPWpGaD
Rifampicin—CYP3A5—Metabolism—CYP2S1—psoriasis	3.03e-05	0.000381	CbGpPWpGaD
Rifampicin—ABCC3—Metabolism—CARM1—psoriasis	2.99e-05	0.000377	CbGpPWpGaD
Rifampicin—ABCB11—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.92e-05	0.000367	CbGpPWpGaD
Rifampicin—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.88e-05	0.000362	CbGpPWpGaD
Rifampicin—ABCC3—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.8e-05	0.000352	CbGpPWpGaD
Rifampicin—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.8e-05	0.000352	CbGpPWpGaD
Rifampicin—CYP2C19—Metabolism—NDUFA5—psoriasis	2.75e-05	0.000346	CbGpPWpGaD
Rifampicin—ABCB1—Allograft Rejection—TNF—psoriasis	2.69e-05	0.000338	CbGpPWpGaD
Rifampicin—ABCB1—Metabolism—NDUFA5—psoriasis	2.69e-05	0.000338	CbGpPWpGaD
Rifampicin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.67e-05	0.000336	CbGpPWpGaD
Rifampicin—CYP2C8—Metabolism—CYP2S1—psoriasis	2.62e-05	0.00033	CbGpPWpGaD
Rifampicin—SLCO1A2—Metabolism—CARM1—psoriasis	2.61e-05	0.000328	CbGpPWpGaD
Rifampicin—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.57e-05	0.000323	CbGpPWpGaD
Rifampicin—ABCC1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.52e-05	0.000317	CbGpPWpGaD
Rifampicin—CYP2C9—Metabolism—NDUFA5—psoriasis	2.51e-05	0.000316	CbGpPWpGaD
Rifampicin—ABCC5—Metabolism—CAT—psoriasis	2.5e-05	0.000314	CbGpPWpGaD
Rifampicin—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	2.5e-05	0.000314	CbGpPWpGaD
Rifampicin—ABCC5—Disease—HLA-A—psoriasis	2.48e-05	0.000312	CbGpPWpGaD
Rifampicin—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.44e-05	0.000307	CbGpPWpGaD
Rifampicin—UGT1A1—Metabolism—CARM1—psoriasis	2.43e-05	0.000306	CbGpPWpGaD
Rifampicin—CYP3A43—Metabolism—APOE—psoriasis	2.43e-05	0.000305	CbGpPWpGaD
Rifampicin—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.39e-05	0.000301	CbGpPWpGaD
Rifampicin—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	2.38e-05	0.0003	CbGpPWpGaD
Rifampicin—ABCC1—Metabolism—CARM1—psoriasis	2.35e-05	0.000295	CbGpPWpGaD
Rifampicin—CYP2C19—Metabolism—CYP2S1—psoriasis	2.34e-05	0.000295	CbGpPWpGaD
Rifampicin—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.34e-05	0.000294	CbGpPWpGaD
Rifampicin—ABCC5—Disease—APOE—psoriasis	2.32e-05	0.000292	CbGpPWpGaD
Rifampicin—ABCB1—Metabolism—CYP2S1—psoriasis	2.29e-05	0.000287	CbGpPWpGaD
Rifampicin—SLCO1B1—Metabolism—CARM1—psoriasis	2.23e-05	0.00028	CbGpPWpGaD
Rifampicin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.19e-05	0.000276	CbGpPWpGaD
Rifampicin—CYP4A11—Metabolism—CAT—psoriasis	2.17e-05	0.000272	CbGpPWpGaD
Rifampicin—ABCC5—Disease—NOS2—psoriasis	2.16e-05	0.000272	CbGpPWpGaD
Rifampicin—CYP1A2—Metabolism—NDUFA5—psoriasis	2.15e-05	0.00027	CbGpPWpGaD
Rifampicin—CYP2C9—Metabolism—CYP2S1—psoriasis	2.14e-05	0.000269	CbGpPWpGaD
Rifampicin—CYP3A43—Metabolism—PPARG—psoriasis	2.11e-05	0.000266	CbGpPWpGaD
Rifampicin—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.08e-05	0.000262	CbGpPWpGaD
Rifampicin—CYP3A7—Metabolism—CARM1—psoriasis	2.05e-05	0.000257	CbGpPWpGaD
Rifampicin—SLCO1B3—Metabolism—CAT—psoriasis	2.04e-05	0.000257	CbGpPWpGaD
Rifampicin—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2e-05	0.000252	CbGpPWpGaD
Rifampicin—ABCC5—Metabolism—APOE—psoriasis	1.94e-05	0.000244	CbGpPWpGaD
Rifampicin—ABCB11—Metabolism—CAT—psoriasis	1.92e-05	0.000242	CbGpPWpGaD
Rifampicin—CYP2A6—Metabolism—CARM1—psoriasis	1.88e-05	0.000236	CbGpPWpGaD
Rifampicin—ABCC3—Metabolism—CAT—psoriasis	1.84e-05	0.000232	CbGpPWpGaD
Rifampicin—CYP1A2—Metabolism—CYP2S1—psoriasis	1.82e-05	0.000229	CbGpPWpGaD
Rifampicin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.77e-05	0.000223	CbGpPWpGaD
Rifampicin—ABCC5—Disease—TYK2—psoriasis	1.77e-05	0.000223	CbGpPWpGaD
Rifampicin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.71e-05	0.000215	CbGpPWpGaD
Rifampicin—ABCC5—Metabolism—PPARG—psoriasis	1.69e-05	0.000213	CbGpPWpGaD
Rifampicin—CYP4A11—Metabolism—APOE—psoriasis	1.68e-05	0.000212	CbGpPWpGaD
Rifampicin—CYP3A4—Metabolism—NDUFA5—psoriasis	1.66e-05	0.000208	CbGpPWpGaD
Rifampicin—SLCO1A2—Metabolism—CAT—psoriasis	1.6e-05	0.000202	CbGpPWpGaD
Rifampicin—ABCC5—Disease—CD4—psoriasis	1.6e-05	0.000201	CbGpPWpGaD
Rifampicin—SLCO1B3—Metabolism—APOE—psoriasis	1.59e-05	0.000199	CbGpPWpGaD
Rifampicin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.55e-05	0.000195	CbGpPWpGaD
Rifampicin—CYP2B6—Metabolism—CARM1—psoriasis	1.51e-05	0.00019	CbGpPWpGaD
Rifampicin—UGT1A1—Metabolism—CAT—psoriasis	1.5e-05	0.000188	CbGpPWpGaD
Rifampicin—ABCB11—Metabolism—APOE—psoriasis	1.49e-05	0.000188	CbGpPWpGaD
Rifampicin—CYP2E1—Metabolism—CARM1—psoriasis	1.48e-05	0.000186	CbGpPWpGaD
Rifampicin—CYP3A5—Metabolism—CARM1—psoriasis	1.48e-05	0.000186	CbGpPWpGaD
Rifampicin—CYP4A11—Metabolism—PPARG—psoriasis	1.47e-05	0.000184	CbGpPWpGaD
Rifampicin—ABCC1—Metabolism—CAT—psoriasis	1.44e-05	0.000182	CbGpPWpGaD
Rifampicin—ABCC1—Disease—HLA-A—psoriasis	1.43e-05	0.00018	CbGpPWpGaD
Rifampicin—ABCC3—Metabolism—APOE—psoriasis	1.43e-05	0.00018	CbGpPWpGaD
Rifampicin—CYP3A4—Metabolism—CYP2S1—psoriasis	1.41e-05	0.000177	CbGpPWpGaD
Rifampicin—SLCO1B3—Metabolism—PPARG—psoriasis	1.38e-05	0.000174	CbGpPWpGaD
Rifampicin—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.37e-05	0.000173	CbGpPWpGaD
Rifampicin—SLCO1B1—Metabolism—CAT—psoriasis	1.37e-05	0.000172	CbGpPWpGaD
Rifampicin—ABCC1—Disease—APOE—psoriasis	1.34e-05	0.000168	CbGpPWpGaD
Rifampicin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.33e-05	0.000167	CbGpPWpGaD
Rifampicin—ABCB11—Metabolism—PPARG—psoriasis	1.3e-05	0.000164	CbGpPWpGaD
Rifampicin—CYP2C8—Metabolism—CARM1—psoriasis	1.28e-05	0.000161	CbGpPWpGaD
Rifampicin—CYP3A7—Metabolism—CAT—psoriasis	1.26e-05	0.000158	CbGpPWpGaD
Rifampicin—ABCC1—Disease—NOS2—psoriasis	1.25e-05	0.000157	CbGpPWpGaD
Rifampicin—ABCC3—Metabolism—PPARG—psoriasis	1.25e-05	0.000157	CbGpPWpGaD
Rifampicin—SLCO1A2—Metabolism—APOE—psoriasis	1.25e-05	0.000157	CbGpPWpGaD
Rifampicin—ABCC5—Disease—STAT3—psoriasis	1.24e-05	0.000156	CbGpPWpGaD
Rifampicin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.23e-05	0.000154	CbGpPWpGaD
Rifampicin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.2e-05	0.000151	CbGpPWpGaD
Rifampicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.17e-05	0.000147	CbGpPWpGaD
Rifampicin—UGT1A1—Metabolism—APOE—psoriasis	1.16e-05	0.000146	CbGpPWpGaD
Rifampicin—CYP2A6—Metabolism—CAT—psoriasis	1.15e-05	0.000145	CbGpPWpGaD
Rifampicin—CYP2C19—Metabolism—CARM1—psoriasis	1.14e-05	0.000144	CbGpPWpGaD
Rifampicin—ABCC1—Metabolism—APOE—psoriasis	1.12e-05	0.000141	CbGpPWpGaD
Rifampicin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.12e-05	0.000141	CbGpPWpGaD
Rifampicin—ABCB1—Metabolism—CARM1—psoriasis	1.12e-05	0.00014	CbGpPWpGaD
Rifampicin—SLCO1A2—Metabolism—PPARG—psoriasis	1.09e-05	0.000137	CbGpPWpGaD
Rifampicin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.07e-05	0.000134	CbGpPWpGaD
Rifampicin—SLCO1B1—Metabolism—APOE—psoriasis	1.07e-05	0.000134	CbGpPWpGaD
Rifampicin—CYP2C9—Metabolism—CARM1—psoriasis	1.04e-05	0.000131	CbGpPWpGaD
Rifampicin—ABCC1—Disease—TYK2—psoriasis	1.02e-05	0.000129	CbGpPWpGaD
Rifampicin—UGT1A1—Metabolism—PPARG—psoriasis	1.01e-05	0.000127	CbGpPWpGaD
Rifampicin—CYP3A7—Metabolism—APOE—psoriasis	9.78e-06	0.000123	CbGpPWpGaD
Rifampicin—ABCC1—Metabolism—PPARG—psoriasis	9.77e-06	0.000123	CbGpPWpGaD
Rifampicin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.75e-06	0.000123	CbGpPWpGaD
Rifampicin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.56e-06	0.00012	CbGpPWpGaD
Rifampicin—CYP2B6—Metabolism—CAT—psoriasis	9.31e-06	0.000117	CbGpPWpGaD
Rifampicin—SLCO1B1—Metabolism—PPARG—psoriasis	9.28e-06	0.000117	CbGpPWpGaD
Rifampicin—ABCC1—Disease—CD4—psoriasis	9.24e-06	0.000116	CbGpPWpGaD
Rifampicin—CYP2E1—Metabolism—CAT—psoriasis	9.12e-06	0.000115	CbGpPWpGaD
Rifampicin—CYP3A5—Metabolism—CAT—psoriasis	9.1e-06	0.000114	CbGpPWpGaD
Rifampicin—CYP2A6—Metabolism—APOE—psoriasis	8.96e-06	0.000113	CbGpPWpGaD
Rifampicin—CYP1A2—Metabolism—CARM1—psoriasis	8.91e-06	0.000112	CbGpPWpGaD
Rifampicin—ABCC5—Disease—IL6—psoriasis	8.65e-06	0.000109	CbGpPWpGaD
Rifampicin—CYP3A7—Metabolism—PPARG—psoriasis	8.52e-06	0.000107	CbGpPWpGaD
Rifampicin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.33e-06	0.000105	CbGpPWpGaD
Rifampicin—CYP2C8—Metabolism—CAT—psoriasis	7.88e-06	9.91e-05	CbGpPWpGaD
Rifampicin—CYP2A6—Metabolism—PPARG—psoriasis	7.81e-06	9.82e-05	CbGpPWpGaD
Rifampicin—CYP2B6—Metabolism—APOE—psoriasis	7.23e-06	9.1e-05	CbGpPWpGaD
Rifampicin—ABCC1—Disease—STAT3—psoriasis	7.16e-06	9e-05	CbGpPWpGaD
Rifampicin—CYP2E1—Metabolism—APOE—psoriasis	7.08e-06	8.91e-05	CbGpPWpGaD
Rifampicin—CYP3A5—Metabolism—APOE—psoriasis	7.07e-06	8.89e-05	CbGpPWpGaD
Rifampicin—CYP2C19—Metabolism—CAT—psoriasis	7.03e-06	8.85e-05	CbGpPWpGaD
Rifampicin—CYP3A4—Metabolism—CARM1—psoriasis	6.88e-06	8.65e-05	CbGpPWpGaD
Rifampicin—ABCB1—Metabolism—CAT—psoriasis	6.87e-06	8.64e-05	CbGpPWpGaD
Rifampicin—CYP2C9—Metabolism—CAT—psoriasis	6.41e-06	8.07e-05	CbGpPWpGaD
Rifampicin—CYP2B6—Metabolism—PPARG—psoriasis	6.3e-06	7.92e-05	CbGpPWpGaD
Rifampicin—CYP2E1—Metabolism—PPARG—psoriasis	6.17e-06	7.76e-05	CbGpPWpGaD
Rifampicin—CYP3A5—Metabolism—PPARG—psoriasis	6.16e-06	7.74e-05	CbGpPWpGaD
Rifampicin—CYP2C8—Metabolism—APOE—psoriasis	6.12e-06	7.7e-05	CbGpPWpGaD
Rifampicin—CYP1A2—Metabolism—CAT—psoriasis	5.48e-06	6.89e-05	CbGpPWpGaD
Rifampicin—CYP2C19—Metabolism—APOE—psoriasis	5.47e-06	6.87e-05	CbGpPWpGaD
Rifampicin—ABCB1—Metabolism—APOE—psoriasis	5.33e-06	6.71e-05	CbGpPWpGaD
Rifampicin—CYP2C8—Metabolism—PPARG—psoriasis	5.33e-06	6.71e-05	CbGpPWpGaD
Rifampicin—ABCC1—Disease—IL6—psoriasis	5e-06	6.29e-05	CbGpPWpGaD
Rifampicin—CYP2C9—Metabolism—APOE—psoriasis	4.98e-06	6.27e-05	CbGpPWpGaD
Rifampicin—CYP2C19—Metabolism—PPARG—psoriasis	4.76e-06	5.99e-05	CbGpPWpGaD
Rifampicin—ABCB1—Metabolism—PPARG—psoriasis	4.65e-06	5.84e-05	CbGpPWpGaD
Rifampicin—CYP2C9—Metabolism—PPARG—psoriasis	4.34e-06	5.46e-05	CbGpPWpGaD
Rifampicin—CYP1A2—Metabolism—APOE—psoriasis	4.26e-06	5.36e-05	CbGpPWpGaD
Rifampicin—CYP3A4—Metabolism—CAT—psoriasis	4.23e-06	5.32e-05	CbGpPWpGaD
Rifampicin—CYP1A2—Metabolism—PPARG—psoriasis	3.71e-06	4.67e-05	CbGpPWpGaD
Rifampicin—CYP3A4—Metabolism—APOE—psoriasis	3.29e-06	4.13e-05	CbGpPWpGaD
Rifampicin—CYP3A4—Metabolism—PPARG—psoriasis	2.86e-06	3.6e-05	CbGpPWpGaD
